Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
amphetamine
Hallucinogen |
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
144575-97-7
|
| gptkbp:chemicalFormula |
C13H21NO2S
|
| gptkbp:discoveredBy |
gptkb:Alexander_Shulgin
|
| gptkbp:duration_of_action |
6-8 hours
|
| gptkbp:effect |
psychedelic
hallucinogenic |
| gptkbp:firstSynthesized |
1991
|
| gptkbp:hasSMILES |
CC1=CC(=C(C=C1OC)SCCF)OCCN
|
| https://www.w3.org/2000/01/rdf-schema#label |
2C-T-21
|
| gptkbp:IUPACName |
2-(4-(2-fluoroethylthio)-2,5-dimethoxyphenyl)ethanamine
|
| gptkbp:legal_status_in_Canada |
gptkb:Schedule_III
|
| gptkbp:legal_status_in_United_Kingdom |
Class A
|
| gptkbp:legal_status_in_United_States |
gptkb:Schedule_I
|
| gptkbp:mentions |
gptkb:PiHKAL
|
| gptkbp:molecularWeight |
255.37 g/mol
|
| gptkbp:PubChem_CID |
443501
|
| gptkbp:relatedTo |
gptkb:2C-T-2
gptkb:2C-T-7 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:toxicity |
not well studied
|
| gptkbp:UNII |
6Q6K1Q1K1F
|
| gptkbp:bfsParent |
gptkb:2C_family
|
| gptkbp:bfsLayer |
7
|